Filed: 2026-04-17 AccNo: 0001193125-26-161558 Size: 5 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Knight Jeff E.
Filed:
2026-04-10
AccNo:
0001628280-26-024716
Size:
16 KB
发布时间04/10 20:33 UTC
首次发现04/10 20:37 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 512 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001628280-26-024716
Filing Date: 2026-04-10
Accepted: 2026-04-10 16:33:56
Documents: 1
Period of Report: 2026-04-08
Crinetics Pharmaceuticals, Inc. ( Issuer ) CIK : 0001658247 (see all company filings) EIN. : 263744114 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 4 | wk-form4_1775853233.html | 4
1 | FORM 4 | wk-form4_1775853233.xml | 4
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇